Business
CFN Media Exclusive CEO Interview: Ehave Connect and the Medical Marijuana Industry
CFN Media Exclusive CEO Interview: Ehave Connect and the Medical Marijuana Industry.
About this update from Ehave Inc.
[{"type":"text","content":"\n\n SEATTLE, WA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (\"CannabisFN\"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive CEO interview and article discussing Ehave Inc.(OTCQB: EHVVF) and its proprietary patient management platform, currently in use in both the medical marijuana and mental health industries.\n In the interview, CEO Prateek Dwivedi discusses the features and benefits of Ehave Connect, the company’s comprehensive software solution. Mr. Dwivedi also talks about the company’s partnership with MedReleaf, a major producer of medical marijuana in Canada, as well as Ehave’s plans for further penetration of the medical marijuana market. New Concussions Assessment Tool Ehave is focused on empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis, and treatment. With between 1.6 million and 3.8 million sports-related concussions each year, mild traumatic brain injury represents a major problem in both amateur and professional sports. It’s estimated that up to half of concussions go unreported where they can cause lasting damage. The company recently launched a new baseline concussion assessment tool on its Ehave Connect platform. The test records baseline concussion symptoms using validated cognitive assessments and, via the Ehave Core Platform, provides extensive information about the athlete’s history with concussions upon repeat assessment following acute injury. The goal is to track treatment progress and help guide return-to-sport strategies. “Mild traumatic brain injury, or concussion, is the most common type of traumatic brain injury and is part of the target group of mental and cognitive conditions that Ehave is currently focused on,” said Ehave CEO Prateek Dwivedi in a press release announcing the launch of the new tool. “Initially, we plan to focus marketing of our baseline concussion test on school boards and amateur sports leagues where the need is the greatest.” Cannabinoid Treatment Options The cannabis industry has demonstrated the potential to treat many mental disorders, including mild traumatic brain injury and post-traumatic stress disorder. On February 3, 2017 the company en...